Dialog window

Delsie Braganza

Delsie joined the Focal Point Research team in 2011 and has been an invaluable asset for our clients. With her strong regulatory and quality assurance background, she is able to help clients understand the Canadian and US requirements, set targets to achieve compliance, and attain their goals to get products to market.

Delsie is able to audit facilities, set up and maintain GMP compliant facilities, develop strong quality management systems, and co-ordinate successful Health Canada inspections. In addition to this, Delsie oversees all regulatory compliance reviews and submissions made to Health Canada and the US FDA.

Delsie obtained an Honours Bachelor of Science (Hons. B. Sc.) in Pharmaceutical Chemistry from the University of Toronto, Post-Graduate Certificate in Pharmaceutical Regulatory Affairs and Quality Operations (RAQ) from Seneca College and Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society (RAPS).

When she’s not learning something new, Delsie loves spending time with family, going on road trips or long walks, and swimming.

(905) 271 2709 mail@focalpointresearch.net
Focal Point
  • Home
  • About
  • Team
  • Services
    • Cosmetic Consultants
      • Natural Health Products
      • Topical OTC Drugs
      • Medical Devices
      • Consumer Products
      • FDA Consulting
      • Veterinary Health Product
    • Health Canada Consultants
      • Regulatory Affairs
      • Pharmacovigilance Services
      • MoCRA
      • Ingredient Compliance
      • CEPA
      • Good Manufacturing Practices (GMP) Training
      • Technology
  • Innovation
  • Articles
  • Contact
Select Page
First Amendment Milestone: Federal Court Bars California Prop 65 Cancer Warnings for Diethanolamine (DEA)

First Amendment Milestone: Federal Court Bars California Prop 65 Cancer Warnings for Diethanolamine (DEA)

by Sagarika Sharma | Oct 13, 2026 | California Cosmetic Regulations, U.S. Regulatory

In a landmark decision for cosmetic and personal care manufacturers, a federal court in Sacramento has permanently prohibited the State of California from enforcing Proposition 65 cancer warning mandates for products containing the common surfactant diethanolamine...
Streamlining Post-Market Vigilance: Health Canada Overhauls Guidance on Notifying Foreign Regulatory Actions

Streamlining Post-Market Vigilance: Health Canada Overhauls Guidance on Notifying Foreign Regulatory Actions

by Sagarika Sharma | Oct 13, 2026 | Health Canada Updates

Health Canada has announced a modernized regulatory framework governing how Market Authorization Holders (MAHs) report safety actions and restrictions occurring in international jurisdictions. Officially taking effect on October 1, 2026, the revised guidance...
Health Canada Updates Summary Reporting Guidance for Marketed Drugs and Natural Health Products

Health Canada Updates Summary Reporting Guidance for Marketed Drugs and Natural Health Products

by Sagarika Sharma | Oct 13, 2026 | Health Canada Updates, Importation of NHPs, Natural Health Products

Health Canada has announced an updated version of its foundational guidance, Preparing and Submitting Summary Reports for Marketed Drugs and Natural Health Products – Guidance Document for Industry, officially entering into force on October 1, 2026. Replacing...
First Amendment Milestone: Federal Court Bars California Prop 65 Cancer Warnings for Diethanolamine (DEA)

ICCR: E-labelling and Digital Information General Principles

by Sagarika Sharma | Sep 9, 2026 | Our View

ICCR has published a guide regarding e-labelling and digital information general principles. Through the ICCR, global regulators have established a set of general principles designed to foster globally compatible approaches to digital cosmetic labelling. The digital...
Upcoming Deadlines for Minnesota’s PFAS Reporting

Upcoming Deadlines for Minnesota’s PFAS Reporting

by Sagarika Sharma | Sep 9, 2026 | Our View, U.S. Regulatory, U.S. State Updates

The Minnesota Pollution Control Agency is reminding manufacturers of critical impending deadlines under the state’s PFAS pollution prevention law, commonly known as Amara’s Law. Passed in May 2023, this legislation mandates that businesses must report...
« Older Entries

Recent Posts

  • First Amendment Milestone: Federal Court Bars California Prop 65 Cancer Warnings for Diethanolamine (DEA)
  • FDA issues warning letters to OTC companies over talc testing
  • FDA Warning Letter Trends
  • Streamlining Post-Market Vigilance: Health Canada Overhauls Guidance on Notifying Foreign Regulatory Actions
  • Health Canada Updates Summary Reporting Guidance for Marketed Drugs and Natural Health Products

Recent Comments

    Archives

    • October 2026
    • September 2026
    • August 2026
    • June 2026
    • April 2026
    • February 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • June 2025
    • May 2025
    • March 2025
    • October 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • December 2023
    • November 2023
    • September 2023
    • August 2023
    • July 2023
    • June 2023
    • January 2023
    • December 2022
    • November 2022
    • July 2022
    • June 2022
    • April 2022
    • March 2022
    • October 2021
    • July 2021
    • April 2021
    • March 2021
    • February 2021
    • January 2021
    • November 2020
    • October 2020
    • August 2020
    • July 2020
    • June 2020
    • May 2020
    • April 2020
    • March 2020
    • February 2020
    • January 2020
    • December 2019
    • November 2019
    • October 2019
    • September 2019
    • August 2019
    • July 2019
    • May 2019
    • April 2019
    • March 2019
    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • October 2018
    • September 2018
    • August 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • January 2018

    Categories

    • California Cosmetic Regulations
    • California Office of Environmental Health Hazard Assessment
    • Canadian Environmental Protection Act
    • Canadian Quality Assurance
    • Canadian Regulatory
    • Cosmetic Ingredient Hotlist
    • Cosmetics
    • Cosmetics
    • Environment and Climate Change Canada
    • European Regulatory
    • Events/Company Updates
    • FDA
    • Federal Plastics Registry
    • Health Canada Updates
    • Importation of NHPs
    • Industry Insight
    • Innovation
    • Medical Device
    • Medical Devices
    • MoCRA
    • Natural Health Products
    • New Mexico
    • OTC Drugs
    • Our View
    • Prop 65
    • Research/Science/Technology
    • Toxic-Free Cosmetics Act
    • U.S. Regulatory
    • U.S. State Updates
    • Uncategorized
    Copyright © 2025 Focal Point Research Inc.
    Privacy Policy | Terms of Use
    Website Design and Development by PLAY